199k views
3 votes
What has been the statistical outcome of including minorities in clinical trials?

User Jay Shin
by
7.7k points

1 Answer

6 votes

Final answer:

The inclusion of minorities in clinical trials has led to a better understanding of different ethnic groups' health needs, improved participation of under-represented communities in research, and has socioeconomic benefits. It ensures treatments are effective across diverse groups and helps address health disparities. Furthermore, it contributes to economic growth by maximizing innovation and diversity in scientific fields.

Step-by-step explanation:

The statistical outcome of including minorities in clinical trials can be seen in various aspects of medical and scientific research. In the realm of health disparities, the inclusion of minorities in clinical trials has contributed to a more comprehensive understanding of unique healthcare needs and responses to treatments among different ethnic groups. This is crucial, because, as highlighted by the Henry J. Kaiser Foundation, ethnic minorities often have higher rates of certain diseases and causes of mortality compared to White populations. The inclusion helps to ensure the efficacy and safety of medical interventions across diverse populations.

In terms of social implications, community-based participatory action research (CPAR) and mixed-method approaches have facilitated the increased participation of hard-to-reach groups. This not only provides context to quantitative data but also contributes to the empowerment of minority communities by involving them directly in the research that affects their health outcomes. Furthermore, the employment of affirmative action policies has been associated with small yet substantial shifts in the representation of minorities in selective institutions, positively influencing both academic and health-related fields.

Lastly, barriers to equitable participation, including in the science and technology sectors, have significant negative effects on economic growth. Underrepresentation and discrimination, like the experiences of Mexican-American scientist Lydia Villa-Komaroff, can stifle innovation and contribute to a loss in GDP. Therefore, the inclusion of minorities in scientific processes is integral to maximizing innovation outcomes and economic growth.

User Zellus
by
8.5k points